成就
A prospective, controlled, randomised, open, multicentre, multinational study comparing the efficacy and safety of I\\V to oral ciprofloxacin plus amikacin versus I\\V ceftazidime plus amikacin for the treatment of hospital-acquired pneumonia, Bayer (Singapore) Pte. Ltd., BAY q 3939/0576/ BAY o 9867/1467 OKE22, co-investigator, in Feb 1998
Oxis® and pulmicort turbuhaler® in the management of asthma (OPTIMA), co-investigator in March 1998
King County Acute Lung Injury Study (KCLIP), the survival outcome study of acute lung injury and acute respiratory distress syndrome, Harborview Medical Center, University of Washington, 2002-2004
Unscheduled Readmission of Critically ill Patients, the risk factors and its impact on their outcomes, National Taiwan University Hospital, 2004- present